Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Cancers|June 4, 2020
Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?Maria Corina Plaz Torres, Giorgia Bodini, Manuele Furnari, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 14, 2020
Active pharmacovigilance program in patients affected by psoriasis and inflammatory bowel diseasesHayley M Vergani, Giulia Calvini, Gloria Mangini, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|May 29, 2014
Esophageal motility abnormalities in gastroesophageal reflux diseaseIrene Martinucci, Nicola de Bortoli, Maria Giacchino, et al.
Expert Opinion on Pharmacotherapy|June 29, 2017
Vonoprazan fumarate for the management of acid-related diseasesIrene Martinucci, Corrado Blandizzi, Giorgia Bodini, et al.
Journal of Neurogastroenterology and Motility|July 2, 2020
The Lyon Consensus: Does It Differ From the Previous Ones?Matteo Ghisa, Brigida Barberio, Vincenzo Savarino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 20, 2016
Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann IndexGiorgia Bodini, Edoardo G Giannini, Costanza De Maria, et al.
Cancers|September 9, 2022
Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A ReviewElisa Marabotto, Stefano Kayali, Silvia Buccilli, et al.
Minerva Gastroenterologica E Dietologica|February 21, 2017
Epidemiology and natural history of gastroesophageal reflux diseaseEdoardo Savarino, Elisa Marabotto, Giorgia Bodini, et al.
Expert Review of Clinical Pharmacology|March 3, 2018
Treatment of early stage chronic hepatitis C virus infectionFrancesca Romana Ponziani, Luca Miele, Annalisa Tortora, et al.
Pageof 11